These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6674545)

  • 41. Comparative antibiotic susceptibilities of anaerobes associated with infections of the female reproductive tract.
    Madinger NE; McGregor JA; McKinney PJ; Dembeck ST; Haskell CS; Johnson Z
    Clin Infect Dis; 1993 Jun; 16 Suppl 4():S349-52. PubMed ID: 8324145
    [No Abstract]   [Full Text] [Related]  

  • 42. [Clinical evaluation of aztreonam in the field of obstetrics and gynecology].
    Cho N; Fukunaga K; Kunii K
    Jpn J Antibiot; 1985 Dec; 38(12):3561-72. PubMed ID: 3834139
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Should antimicrobial prophylaxis in colorectal surgery include agents effective against both anaerobic and aerobic microorganisms? A double-blind, multicenter study. The Norwegian Study Group for Colorectal Surgery.
    Surgery; 1985 Apr; 97(4):402-8. PubMed ID: 3885454
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tinidazole v. metronidazole.
    Drug Ther Bull; 1983 Nov; 21(23):90-2. PubMed ID: 6641520
    [No Abstract]   [Full Text] [Related]  

  • 45. [Clinical evaluation of aztreonam in the field of obstetrics and gynecology].
    Ijuin H
    Jpn J Antibiot; 1985 Dec; 38(12):3700-3. PubMed ID: 3834158
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anaerobic vaginosis: treatment with tinidazole vaginal tablets.
    Heikkinen J; Vuopala S
    Gynecol Obstet Invest; 1989; 28(2):98-100. PubMed ID: 2792920
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Preclinical and clinical studies on aztreonam in the field of obstetrics and gynecology].
    Obata I; Hayashi F; Imagawa N; Ochiai K; Koike K; Morimoto O; Hachiya S
    Jpn J Antibiot; 1985 Dec; 38(12):3542-60. PubMed ID: 3834138
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Bacteriological and clinical evaluation of piperacillin in the field of obstetrics and gynecology].
    Ninomiya K; Makino S; Hasegawa Y; Yoshimoto T; Masuda K; Hamaya K
    Jpn J Antibiot; 1982 Oct; 35(10):2323-9. PubMed ID: 6223149
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Experimental and clinical studies of ceftazidime in the field of obstetrics and gynecology].
    Obata I; Ryu F; Ochiai K; Koike K; Morimoto O; Hachiya S
    Jpn J Antibiot; 1983 Dec; 36(12):3491-506. PubMed ID: 6371297
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anaerobic wound infections in cancer patients: comparative trial of clindamycin, tinidazole, and doxycycline.
    Klastersky J; Husson M; Weerts-Ruhl D; Daneau D
    Antimicrob Agents Chemother; 1977 Nov; 12(5):563-70. PubMed ID: 921254
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anaerobic infections: the role of tinidazole. Proceedings of a symposium: Edinburgh, Scotland, 19 and 20 April 1982.
    J Antimicrob Chemother; 1982 Aug; 10 Suppl A():1-187. PubMed ID: 7118766
    [No Abstract]   [Full Text] [Related]  

  • 52. Cefotetan compared with gentamicin and tinidazole in acute abdominal surgery.
    Tanner AG; Thom BT; Strachan CJ
    J Hosp Infect; 1986 Jan; 7(1):49-59. PubMed ID: 2870109
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antibiotic treatment of anaerobic infections.
    Panichi G
    Scand J Infect Dis Suppl; 1989; 62():47-51. PubMed ID: 2685992
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Bacteriological and clinical studies on cefotaxime in obstetrics and gynecology (author's transl)].
    Ninomiya K; Hasegawa Y; Hamatani K; Nishio T
    Jpn J Antibiot; 1981 Apr; 34(4):507-14. PubMed ID: 6270399
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The occurrence, virulence, and antimicrobial resistance of anaerobes in polymicrobial infections.
    Aldridge KE
    Am J Surg; 1995 May; 169(5A Suppl):2S-7S. PubMed ID: 7755163
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antimicrobial susceptibility of clinical isolates of anaerobic bacteria in Ontario, 2010-2011.
    Marchand-Austin A; Rawte P; Toye B; Jamieson FB; Farrell DJ; Patel SN
    Anaerobe; 2014 Aug; 28():120-5. PubMed ID: 24923267
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anaerobic infections of the female genital tract: bacteriologic and therapeutic aspects.
    Thadepalli H; Gorbach SL; Keith L
    Am J Obstet Gynecol; 1973 Dec; 117(8):1034-40. PubMed ID: 4586019
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anaerobic bacteria as cause of infections in female genital organs.
    Bergan T
    Scand J Gastroenterol Suppl; 1983; 85():37-47. PubMed ID: 6353553
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [In vitro activity and clinical evaluation of aztreonam in the field of obstetrics and gynecology].
    Ninomiya K; Ohbayashi F; Hasegawa Y
    Jpn J Antibiot; 1985 Dec; 38(12):3629-33. PubMed ID: 3834148
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Fundamental and clinical studies on aztreonam in obstetrics and gynecology].
    Shimizu T; Haga H; Sakuraba M; Yamashita K; Ishikawa M; Torii Y; Mizoguchi H; Yamazaki T; Yorozu Y; Mure K
    Jpn J Antibiot; 1985 Dec; 38(12):3505-12. PubMed ID: 3834133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.